uk endowment mortgages sell your endowment policy

for those with an endowment mortgage problem

     
  title
   
treasury select committee endowments report

Endowments were the subject of a Treasury Select Committee Report in March 2004. Among other issues, this reviewed the endowments complaint process, including

Other subjects include:

Size of the endowments market

Data presented to us by Cazalet Consulting suggests that over 1.7 million endowment mortgages were sold in 1988 and that sales of endowment policies consistently topped one million a year between 1986 and 1991. Since the early 1990s, however, endowment mortgages have taken a steadily falling share of the overall market, with a particularly abrupt decline over the past four or five years. The latest figures we have available suggest that endowments accounted for just 5% of the new mortgages taken out in 2002.

They suggest that 83% of mortgages sold in 1988 were endowments. But it seems the scandal continues. The committee comments that endowments accounted for just 5% of the new mortgages taken out in 2002. This 5% seems extraordinarily high - are we really satisfied that endowments were the best choice for 5% of new mortgages in 2002? That seems a lot of mortgages for what by then was a very specialist product, and it seems the endowments scandal was continuing at a lower level. The committee shows no sign of alarm at this.

Level of endowment shortfalls

The best available evidence suggests that mortgage endowment policies are currently showing a collective shortfall of around £40 billion. Looking just at policies still being relied upon to repay a mortgage, the collective shortfall is at least £30 billion. Around 80% of policies are currently unlikely to generate enough funds to pay off the mortgage they were originally sold to meet and the average shortfall is currently around £5,500. The balance of probabilities is that both the percentage of policies showing a shortfall and the average size of the shortfall per policy will worsen over the coming years. Without remedial action endowment policies maturing but failing to meet their targets are likely to be an increasingly common problem until 2013, 25 years after the peak in endowment policy sales in 1988.

Aligning the interests of savers and product providers

From the consumer’s perspective, it is perverse that most companies are still charging their full fees on endowment policies when 80% of policies will fail to meet the product’s original objective of paying off the mortgage. A structure in which the fees charged by product providers were tied to the product meeting set investment targets would serve the consumer better, and we recommend that the FSA together with the industry investigate this issue, with a view to developing proposals for reform.

An FT writer decries this as going over ground already covered by a House of Lords Committee. However, we think this was well worth repeating, as it is another step in helping to build a sensible political consensus, which will become that much harder for vested interests to resist.

Closed funds

The switch in asset allocation can have a significant impact on likely returns. The Committee, for example, has been told that on standard actuarial assumptions someone with a £50,000 with-profits pension policy and 10 years to retirement is likely to find their fund reduced by £6000 on retirement if their insurer closes to new business. A similar reduction in returns is likely to apply to endowment policy holders in closed funds....

Royal & Sun Alliance told us that it had considered it prudent to reduce its projected returns to endowment policyholders to “reflect the lower proportion of equities held in the investment portfolio.” For its traditional with-profits funds it now used reprojection rates of 4%, 4.75% and 5.5% and this had “inevitably placed more policies in the red category.” 81% of Royal & Sun Alliance endowment policyholders are currently receiving red reprojection letters, the highest figure among the major insurers we asked for data.

While Royal & Sun Alliance told us that they had written to their clients on the closure of the fund and explained the implications, policyholders were given no particular opportunity to leave the fund and if they chose to do so normal exit penalties would apply.

We have asked several experts and the FSA if they can think of any other industry that sells its customers one product, such as an equity based with-profits endowment policy, and then unilaterally switches the customer into another product, such as a bond-oriented closed fund. No one has yet been able to name another industry which treats its customers in an equivalent fashion.

The treatment of policyholders in closed funds is unfair.

The insurance industry seems to be unique in preserving to itself the right to sell a customer one product and then substitute it with another product which is inferior in key respects. The FSA should examine the case for a regulatory requirement that solvent companies closing the with-profits elements of their operations to new business should, on request, transfer their customers without penalty to another supplier offering a product broadly similar to the one the customer originally bought.